What is the effect of NMN for APOE4 carriers?
NMN is being tracked against this question, but Phoenix has not yet published a ranked result for this exact question.
One intervention, every measured benefit and result that did not improve. See who it moved for, where it stayed neutral or went the other way, and the next hypothesis Phoenix can validate.
Phoenix APOE4 Research · Reviewed by Kevin Tran, APOE4/4 carrier and founder · Data through 2026-08-23 · How to read this research
How to read this
Observational research: real APOE4 carriers tracked over time, each compared with their own earlier self. Members chose their interventions, with no randomisation or placebo group. Everything else they changed is shown beside each result.
Read the full methods and limitsNMN is being tracked against this question, but Phoenix has not yet published a ranked result for this exact question.
Collecting evidence
NMN is being tracked against this question, but Phoenix has not yet published a ranked result for this exact question.
Every carrier who logs a dated start and a repeat test moves this page closer to an answer, including you.
Get an email when Phoenix publishes a meaningful update. At most one combined update each week.
Search by health goal or intervention to see what changed for real members, including results that moved the wrong way.
NMN · 1 outcome shown.
LDL cholesterol: Decrease 26.3 %
Cases: 1
Context affected
One clean curated NMN case lowered LDL cholesterol 26.3% in 42 days; paired values were not published.
NMN
?Collecting evidenceOne clean curated NMN case lowered LDL cholesterol 26.3% in 42 days; paired values were not published.
Not explained by the science yetNMN human trials target NAD+, insulin sensitivity and vascular measures; none establish an LDL-lowering mechanism.
Collecting evidence
NMN is being tracked against LDL cholesterol, but Phoenix has not yet published a ranked result for this exact question.
Every carrier who logs a dated start and a repeat test moves this page closer to an answer, including you.
Get an email when Phoenix publishes a meaningful update. At most one combined update each week.
Context affected this result: Not printed as of Release 001: no known mechanism links NMN to LDL cholesterol. This case is not included in the printed cases or test-next list.
The 43-page study: what members tried, how their bloodwork and wearable results changed, and what else changed alongside them.
Turn evidence into your next test
476 members have already tried, measured and logged. Join Phoenix and your next blood draw joins the same Navigator you are reading.
Full research index
Choose an outcome, like LDL cholesterol or sleep, or an intervention, like training: both paths open the same measured records.